Graybug Vision
Graybug Vision is a clinical-stage pharmaceutical company focused on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve.
Last updated on
About Graybug Vision
Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$218MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
Redwood CityState
CaliforniaCountry
United StatesGraybug Vision
Find your buyer within Graybug Vision